vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Talkspace, Inc. (TALK). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $63.0M, roughly 1.5× Talkspace, Inc.). Talkspace, Inc. runs the higher net margin — 7.6% vs -98.1%, a 105.6% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 29.3%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 17.8%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Talkspace, Inc. is an American company that provides online and mobile therapy services. Founded in 2012 by Oren and Roni Frank, Talkspace connects users with licensed therapists and psychiatrists through web and mobile platforms. The service offers communication through text, audio, and video messaging, as well as live video sessions in some cases. The company is headquartered in New York City.

HIVE vs TALK — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.5× larger
HIVE
$93.1M
$63.0M
TALK
Growing faster (revenue YoY)
HIVE
HIVE
+189.3% gap
HIVE
218.6%
29.3%
TALK
Higher net margin
TALK
TALK
105.6% more per $
TALK
7.6%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
17.8%
TALK

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
TALK
TALK
Revenue
$93.1M
$63.0M
Net Profit
$-91.3M
$4.8M
Gross Margin
-27.1%
Operating Margin
6.1%
Net Margin
-98.1%
7.6%
Revenue YoY
218.6%
29.3%
Net Profit YoY
-234.0%
292.5%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
TALK
TALK
Q4 25
$93.1M
$63.0M
Q3 25
$87.3M
$59.4M
Q2 25
$45.6M
$54.3M
Q1 25
$52.2M
Q4 24
$29.2M
$48.7M
Q3 24
$22.6M
$47.4M
Q2 24
$32.2M
$46.1M
Q1 24
$45.4M
Net Profit
HIVE
HIVE
TALK
TALK
Q4 25
$-91.3M
$4.8M
Q3 25
$-15.8M
$3.3M
Q2 25
$35.0M
$-541.0K
Q1 25
$318.0K
Q4 24
$68.2M
$1.2M
Q3 24
$80.0K
$1.9M
Q2 24
$-18.3M
$-474.0K
Q1 24
$-1.5M
Gross Margin
HIVE
HIVE
TALK
TALK
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q1 25
44.6%
Q4 24
-43.7%
44.2%
Q3 24
-66.1%
45.6%
Q2 24
-7.4%
45.5%
Q1 24
47.8%
Operating Margin
HIVE
HIVE
TALK
TALK
Q4 25
6.1%
Q3 25
3.7%
Q2 25
-3.3%
Q1 25
-2.1%
Q4 24
1.2%
Q3 24
0.2%
Q2 24
-7.6%
Q1 24
-3.7%
Net Margin
HIVE
HIVE
TALK
TALK
Q4 25
-98.1%
7.6%
Q3 25
-18.1%
5.5%
Q2 25
76.8%
-1.0%
Q1 25
0.6%
Q4 24
233.2%
2.5%
Q3 24
0.4%
4.0%
Q2 24
-56.7%
-1.0%
Q1 24
-3.2%
EPS (diluted)
HIVE
HIVE
TALK
TALK
Q4 25
$-0.38
Q3 25
$-0.07
$0.02
Q2 25
$0.18
Q1 25
$0.00
Q4 24
$0.52
$0.01
Q3 24
$0.00
$0.01
Q2 24
$-0.17
$0.00
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
TALK
TALK
Cash + ST InvestmentsLiquidity on hand
$37.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$117.0M
Total Assets
$624.0M
$134.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
TALK
TALK
Q4 25
$37.4M
Q3 25
$39.5M
Q2 25
$54.3M
Q1 25
$60.1M
Q4 24
$40.5M
$76.7M
Q3 24
$31.7M
$119.0M
Q2 24
$114.9M
Q1 24
$120.3M
Stockholders' Equity
HIVE
HIVE
TALK
TALK
Q4 25
$559.3M
$117.0M
Q3 25
$624.6M
$109.1M
Q2 25
$560.5M
$112.9M
Q1 25
$113.4M
Q4 24
$430.9M
$117.4M
Q3 24
$275.5M
$117.6M
Q2 24
$268.6M
$114.0M
Q1 24
$119.6M
Total Assets
HIVE
HIVE
TALK
TALK
Q4 25
$624.0M
$134.9M
Q3 25
$693.0M
$129.1M
Q2 25
$628.7M
$132.8M
Q1 25
$134.2M
Q4 24
$478.6M
$138.7M
Q3 24
$334.7M
$138.2M
Q2 24
$133.8M
Q1 24
$138.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
TALK
TALK
Operating Cash FlowLast quarter
$46.0M
$5.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
TALK
TALK
Q4 25
$46.0M
$5.4M
Q3 25
$-10.6M
$4.7M
Q2 25
$10.2M
$-351.0K
Q1 25
$-1.2M
Q4 24
$-28.5M
$3.7M
Q3 24
$-2.2M
$6.2M
Q2 24
$-4.4M
$4.8M
Q1 24
$-3.4M
Free Cash Flow
HIVE
HIVE
TALK
TALK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
$4.5M
Q1 24
$-3.8M
FCF Margin
HIVE
HIVE
TALK
TALK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
9.7%
Q1 24
-8.3%
Capex Intensity
HIVE
HIVE
TALK
TALK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
92.5%
Q3 24
143.9%
Q2 24
0.7%
Q1 24
0.8%
Cash Conversion
HIVE
HIVE
TALK
TALK
Q4 25
1.13×
Q3 25
1.46×
Q2 25
0.29×
Q1 25
-3.90×
Q4 24
-0.42×
3.02×
Q3 24
-26.94×
3.31×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

TALK
TALK

Payor Revenue$47.7M76%
Dte Revenue$11.6M18%
Consumer$3.7M6%

Related Comparisons